Distinguished Professor Emeritus Department of Nutrition and School of Medicine University of California, Davis Copyright 2000-2026 Linus Pauling Institute Figure Alternative Text Figure 1
Improved Cardiovascular Health: Studies show GLP-1 agonists can lower blood pressure and cholesterol, reducing the risk of heart disease
Cavero-Redondo I, Martinez-Vizcaino V, Fernandez-Rodriguez R, Saz-Lara A, Pascual-Morena C, lvarez-Bueno C
INTRODUCTION Worldwide, liver diseases constitute a significant and prevalent factor in mortality rates, with cirrhosis, in particular, accounting for approximately 1.16 million fatalities each year, positioning it as the 11th leading cause of death